New innovative product launches at American Association for Cancer Research (AACR) Annual Meeting add to broad portfolio of NGS solutions High-speed QIAxpert accelerates quantification and quality ...
CLC bio, a QIAGEN company (NASDAQ:QGEN)(FWB:QIA), today announced in collaboration with Korilog the release of the KLAST plug-in for CLC Genomics Workbench and CLC Main Workbench to accelerate the ...
Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...
QIAGEN CLC Genomics Workbench is a powerful solution to analyze and visualize next generation sequencing (NGS) data. Powered by cutting-edge technology and accelerated algorithms, it supports a ...
In this webinar, we will present QIAGEN CLC Genomics Workbench and its utility for bacterial isolate identification, strain discrimination using core genome multi-locus typing (cgMLST) and detailed ...
It strengthens QIAGEN’s rapidly emerging portfolio of “universal” products that can be used with any NGS sequencer as well as providing a key element to the portfolio of automated solutions for the ...
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced two important new product launches which address workflow challenges in next-generation sequencing (NGS) applications. QIAGEN ...
The plugin for the Qiagen Microbial Genomics Pro Suite and CLC Genomics Workbench expands the firm’s platform for NGS bioinformatics. It offers support for shotgun metagenomics and microbiome ...
Dr. Pearson: QIAGEN Digital Insights is a leading provider of bioinformatics solutions for analysis, interpretation, and data science. Our customers are increasingly moving toward single-cell ...
The innovative QIAxpert ® instrument accelerates quantification and quality control of DNA and RNA samples for next-generation sequencing (NGS), while the new CLC Cancer Research Workbench is the ...
VENLO, Netherlands, and SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Element Biosciences, Inc. today announced a strategic partnership to offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results